Neuromodulation: The Science
February 28 to March 2, 2022 | Kaua’i, Hawai’i
Neuromodulation: The Science exists to advance research, dissemination of knowledge, and implementation of new findings within neuromodulation. Conference founder, Elliot Krames, MD established the journal Neuromodulation: Technology at the Neural Interface in 1998 as the preeminent journal to advance basic science research in the field of neuromodulation. Neuromodulation: The Science is the next step.
Through partnerships with Neuromodec, the program integrates brain stimulation, imaging, AR/VR wearables, and digital healthcare to provide attendees with relevant and up-to-date insights on emerging science and technologies from bench-top to bedside and home use.
Produced by Neurovations Education
Why Choose Us?
Our team has over 14 years experience developing and managing medical education. Having contributed to more than 400 CME conferences, on 6 continents, from 50 attendees to over 20,000, you’re in good hands with Neurovations Education.
Neurovations Education is accredited to provide AMA PRA Category 1 CreditsTM.
Let us organize and maintain the your CME in compliance with ACCME, CMA/IMQ, FDA, OIG, AMA, California Assembly Bill 1195, PhRMA Code, Advamed, and CEJA rules, guidelines and regulations
Neurovations Education is a leader in medical education, establishing the oldest CME pain meeting in California (the Napa Pain Conference). Since then, Neurovations has emerged as an industry leader by placing quality education at the forefront of conference design.
Although results can’t be guaranteed, our Kaua’i Pain Conference and Napa Pain Conference have grown year over year. in 2021, We saw a 200% increase in online attandance.
Quality education, enthusiastic service, and a well-crafted program yield strong results.
Contact Education@Neurovations.com to take your conference to the next level.
Learn about the NIH’s H.E.A.L. Initiative to combat Opioid Use Disorder and improve Pain management.
Learn to optimize the patient-provider dynamic to engender patient trust and willingness to taper opioids.
Keep up to date on Neuromodulation: The Science news, meetings, and events.